Table 3.

Medical History of Control Patients

No.	Sex	Noninsp Muscle	Age (yr)	Removed Tumor	Relevant Medical History	MV (h)	BMI (kg/m2)	FEV1	FEV1%pred	FEV1/FVC %pred	FVC	FVC %pred	VC %pred
1*	M	SA	52	pT3N0M0	Cigarette smoker, diabetes mellitus II, hypertension	1.5	25	2.3	68	0.69	3.3	76	NA
2*	M	SA	22	pT1bN0M0	Cigarette smoker	2.0	23	4.7	103	0.71	6.7	121	NA
3	M	LD	66	pT2aN1M0	Cigarette smoker, hypertension, prostate cancer, COPD	2.0	24	2.7	82	0.66	4.2	NA	97
4	F	LD	58	pT1aN0M0	None	2.0	28	2.9	104	0.77	3.7	NA	116
5	M	LD	60	pT1aN1M0	Cigarette smoker, s/p right upper lobectomy for T1 N0 M0 lung cancer, pulmonary tuberculosis s/p successful drug therapy	1.5	24	3.8	97	0.67	5.6	113	108
6	M	LD	56	pT4N2M0	Cigarette smoker, COPD	2.0	21	3.1	78	0.52	5.9	118	NA
7	M	LD	70	pT1bN1M0	Cigarette smoker, s/p basal cell cancer skin	1.5	30	2.9	89	0.69	4.3	NA	96
8	F	LD	60	pT2aN0R0	Hypertension	0.75	26	2.9	127	0.86	3.4	NA	120
9	F	LD	59	Cyst	Cigarette smoker	0.75	28	2.0	79	0.75	NA	NA	NA
10	F	LD	64	pT1bN0M0	COPD	1.25	26	1.9	76	0.62	3.1	NA	NA
11	F	LD	59	Adenocarcinoma CT2BN2M1A	Cigarette smoker, cholecystectomy, COPD	0.75	21	2.1	76	0.64	3.2	101	94
12	M	LD	52	pT2N0M0	Cigarette smoker	1.00	23	3.2	81	0.73	4.7	110	NA
13	M	LD	64	Bronchiectasis and inflammation, benign	Hypertension, 6 yr ago MI with PCI of LAD artery, diabetes mellitus II	1.00	31	2.41	92	0.72	3.3	86	86
14	F	LD	74	Inflammation with central necrosis, benign	Bronchiectasis and allergic bronchopulmonary aspergillosis	2.50	21	1.79	82	0.67	2.7	103	NA

Definition of abbreviations: %pred = percentage of predicted value; BMI = body mass index; COPD = chronic obstructive pulmonary disease; LAD = left anterior descending artery; LD = latissimus dorsi; MI = myocardial infarct; MV = mechanical ventilation; NA = not available; No. = number; Noninsp Muscle = muscle biopsy from noninspiratory muscle; PCI = percutaneous coronary intervention; SA = serratus anterior; s/p = status post.

^*Lung function of these patients was measured after surgery where biopsy was obtained.